ZNF676

gene
On this page

Summary

ZNF676 (zinc finger protein 676, HGNC:20429) is a protein-coding gene on chromosome 19p12, encoding Zinc finger protein 676 (Q8N7Q3). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in nucleus.

Source: NCBI Gene 163223 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 108 total
  • MANE Select transcript: NM_001001411

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20429
Approved symbolZNF676
Namezinc finger protein 676
Location19p12
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000196109
Ensembl biotypeprotein_coding
Entrez163223

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 3 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000397121, ENST00000650058, ENST00000651839, ENST00000904872

RefSeq mRNA: 1 — MANE Select: NM_001001411 NM_001001411

CCDS: CCDS42539

Canonical transcript exons

ENST00000395385 — 0 exons

Expression profiles

Bgee: expression breadth ubiquitous, 119 present calls, max score 83.06.

FANTOM5 (CAGE): breadth broad, TPM avg 0.8813 / max 456.5353, expressed in 185 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1802490.8034180
1802480.077929

Top tissues by expression

129 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099183.06gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047380.86gold quality
thyroid glandUBERON:000204670.35gold quality
left lobe of thyroid glandUBERON:000112069.48gold quality
right uterine tubeUBERON:000130269.28gold quality
right lobe of thyroid glandUBERON:000111968.59gold quality
smooth muscle tissueUBERON:000113567.94gold quality
islet of LangerhansUBERON:000000666.92gold quality
left coronary arteryUBERON:000162666.74gold quality
heart left ventricleUBERON:000208466.69gold quality
right coronary arteryUBERON:000162566.67gold quality
heartUBERON:000094866.42gold quality
apex of heartUBERON:000209866.26gold quality
descending thoracic aortaUBERON:000234566.08gold quality
body of uterusUBERON:000985366.07gold quality
right atrium auricular regionUBERON:000663165.95gold quality
ascending aortaUBERON:000149665.68gold quality
thoracic aortaUBERON:000151565.68gold quality
testisUBERON:000047365.57gold quality
fallopian tubeUBERON:000388965.24gold quality
omental fat padUBERON:001041464.82gold quality
pancreasUBERON:000126464.76gold quality
calcaneal tendonUBERON:000370164.29gold quality
myometriumUBERON:000129663.90gold quality
body of pancreasUBERON:000115063.87gold quality
left testisUBERON:000453363.84gold quality
right testisUBERON:000453463.77gold quality
left uterine tubeUBERON:000130363.42gold quality
lower esophagus muscularis layerUBERON:003583363.24gold quality
lower esophagusUBERON:001347363.21gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-MTAB-6142no10.07
E-ANND-3no2.21

Regulation

Is transcription factor: yes

JASPAR motifs

MotifNameFamily
MA2569.1ZNF676More than 3 adjacent zinc fingers

JASPAR matrix evidence (PMIDs): PMID:39605368

miRNA regulators (miRDB)

74 targeting ZNF676, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3925-3P100.0069.951237
HSA-MIR-6833-3P100.0070.633197
HSA-MIR-4768-5P100.0069.492861
HSA-MIR-3064-3P100.0070.091254
HSA-MIR-6873-3P100.0071.422626
HSA-MIR-4776-3P100.0068.731340
HSA-MIR-188-3P100.0068.761240
HSA-MIR-1252-5P100.0069.802774
HSA-MIR-656-3P100.0072.152788
HSA-MIR-1212199.9966.64255
HSA-MIR-511-3P99.9968.851467
HSA-MIR-4715-3P99.9866.03670
HSA-MIR-548AN99.9770.912817
HSA-MIR-146A-5P99.9668.93988
HSA-MIR-146B-5P99.9669.13977
HSA-MIR-23A-3P99.9574.243163
HSA-MIR-23B-3P99.9574.243163
HSA-MIR-23C99.9573.923192
HSA-MIR-6845-3P99.9466.881439
HSA-MIR-7153-5P99.9468.891006
HSA-MIR-6809-3P99.9171.453814
HSA-MIR-7162-3P99.8968.161682
HSA-MIR-548E-5P99.8972.734486
HSA-MIR-200A-5P99.7669.10949
HSA-MIR-200B-5P99.7669.05948
HSA-MIR-4755-5P99.7170.342716
HSA-MIR-5006-3P99.7170.262728
HSA-MIR-580-3P99.6769.231841
HSA-MIR-10393-5P99.6568.011368
HSA-MIR-1251-3P99.6467.211408

Literature-anchored findings (GeneRIF, showing 2)

  • Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans. (PMID:23001564)
  • Transcriptome wide association study results identified two novel genes as statistically significantly associated with nonobstructive azoospermia susceptibility: PILRA and ZNF676. (PMID:29202958)

Cross-species orthologs

0 orthologs

Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)

Protein

Protein identifiers

Zinc finger protein 676Q8N7Q3 (reviewed: Q8N7Q3)

All UniProt accessions (2): Q8N7Q3, A0A3B3ITU2

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (1): NP_001001411* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR050758Znf_C2H2-typeFamily

Pfam: PF00096, PF13465

UniProt features (23 total): zinc finger region 15, sequence variant 3, sequence conflict 3, chain 1, domain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8N7Q3-F172.690.24

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 42 (showing top): chr19p12, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MIR23A_3P_MIR23B_3P, MIR23C, MIR6809_3P, MIR6833_3P, MIR6873_3P, MIR4768_5P, MIR892C_5P, MIR3925_3P, MIR3064_3P, MIR511_3P, MIR4776_3P

GO Biological Process (2): regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357)

GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

322 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF676CTC1Q2NKJ3697
ZNF676DHX35Q9H5Z1667
ZNF676ACYP2P14621667
ZNF676STN1Q9H668663
ZNF676PXKQ7Z7A4604
ZNF676ALG1L2C9J202576
ZNF676DCAF4Q8WV16571
ZNF676OR2G6Q5TZ20474
ZNF676METTL21CQ5VZV1465
ZNF676TERTO14746446
ZNF676MEIS3Q99687443
ZNF676RTEL1Q9NZ71436
ZNF676CFAP57Q96MR6418
ZNF676DNAH11Q96DT5409
ZNF676A0A087WVV2A0A087WVV2399

IntAct

3 interactions, top by confidence:

ABTypeScore
ECE1ZNF676psi-mi:“MI:0915”(physical association)0.370
TP63HNRNPRpsi-mi:“MI:0914”(association)0.350

BioGRID (1): ZNF676 (Affinity Capture-MS)

ESM2 similar proteins: A2VDQ7, A6NK75, A6NN14, A6NNF4, A8MQ14, A8MTY0, A8MXY4, B7Z6K7, E9QAG8, O43345, O75290, O75373, O75437, P0CJ79, P10751, P17017, P17019, P17035, P17038, P18749, P35789, P51522, Q03923, Q03938, Q05481, Q14585, Q3SYV7, Q4V348, Q5R5U3, Q5R8X1, Q5R9F0, Q5SXM1, Q6P5C7, Q6ZN08, Q6ZN57, Q6ZR52, Q86V71, Q86XN6, Q8IYB9, Q8N7Q3

Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

108 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance87
Likely benign11
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

498 predictions. Top by Δscore:

VariantEffectΔscore
19:22196430:AGGAC:Adonor_gain1.0000
19:22181582:TATAA:Tacceptor_gain0.9900
19:22181584:TAA:Tacceptor_gain0.9900
19:22181587:C:CCacceptor_gain0.9900
19:22181583:ATAA:Aacceptor_gain0.9800
19:22181584:TAAC:Tacceptor_loss0.9700
19:22181587:CT:Cacceptor_loss0.9700
19:22181588:T:Cacceptor_loss0.9700
19:22193107:AATAC:Aacceptor_loss0.9600
19:22193108:ATACC:Aacceptor_loss0.9600
19:22193109:TACCT:Tacceptor_loss0.9600
19:22193110:ACCT:Aacceptor_loss0.9600
19:22193111:CC:Cacceptor_loss0.9600
19:22193113:T:Cacceptor_loss0.9600
19:22196598:AC:Adonor_gain0.9600
19:22196599:CC:Cdonor_gain0.9600
19:22196639:T:Adonor_gain0.9600
19:22193114:G:Cacceptor_loss0.9500
19:22196429:CAGG:Cdonor_gain0.9500
19:22196430:AGGA:Adonor_gain0.9500
19:22196592:ATTCT:Adonor_loss0.9400
19:22196594:TCTCA:Tdonor_loss0.9400
19:22196595:CTCAC:Cdonor_loss0.9400
19:22196596:T:TAdonor_loss0.9400
19:22196597:CA:Cdonor_loss0.9400
19:22196599:C:Gdonor_loss0.9400
19:22181585:AA:Aacceptor_gain0.9300
19:22193010:ACCT:Adonor_loss0.9300
19:22193011:CCTA:Cdonor_loss0.9300
19:22193012:CTAC:Cdonor_loss0.9300

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000013190 (19:22244216 G>A), RS1000077987 (19:22208440 A>G), RS1000151155 (19:22208208 G>T), RS1000161076 (19:22253059 C>A), RS1000187492 (19:22213981 T>A,C,G), RS1000222285 (19:22209325 A>C,G,T), RS1000261703 (19:22248985 C>T), RS1000276452 (19:22252787 A>G), RS1000351697 (19:22218644 G>A,T), RS1000360572 (19:22258083 G>C), RS1000365660 (19:22183439 G>A), RS1000380326 (19:22254462 A>T), RS1000428774 (19:22260064 G>C,T), RS1000489110 (19:22244095 G>A,C), RS1000501492 (19:22254429 G>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST000669_1Telomere length2.000000e-06
GCST001697_1Telomere length1.000000e-08
GCST008554_7Atorvastatin-induced myopathy3.000000e-06

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

18 total (human), top 18 by PubMed support.

ChemicalActions (top 5)PubMed papers
enzacamenedecreases expression1
pentanaldecreases expression1
Resveratrolaffects cotreatment, decreases expression1
Amiodaroneincreases expression1
Copperaffects cotreatment, decreases expression1
Dimethoateincreases expression1
Endosulfandecreases expression1
Estradiolincreases expression1
Iopanoic Acidincreases expression1
Methimazoleincreases expression1
Methoxychlorincreases expression1
Methylmercury Compoundsincreases expression1
Propylthiouracilincreases expression1
Tetrachlorodibenzodioxindecreases expression1
Triiodothyroninedecreases expression, increases expression1
Aflatoxin B1increases expression1
Cadmium Chlorideincreases expression1
Iodoacetic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): myopathy